Trials / Completed
CompletedNCT00306176
Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- Aristotle University Of Thessaloniki · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study is to investigate the influence of systemic exercise, rosiglitazone administration and combined pharmaceutical and lifestyle intervention on cardiovascular risk factors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosiglitazone |
Timeline
- Start date
- 2005-01-01
- Completion
- 2006-10-01
- First posted
- 2006-03-23
- Last updated
- 2007-04-04
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT00306176. Inclusion in this directory is not an endorsement.